$2.2M for Cytogel

Xconomy Boston — 

Cytogel Pharma, a Darien, CT-based biopharmaceutical development firm, has raised $2.2 million in equity and rights funding, according to an SEC filing. The company, founded in 2002, says that its strategy is to license promising drugs with the intent of eventually selling them to larger companies, according to its website. Centripetal Capital Partners, based in Stamford, CT, lists Cytogel among its portfolio companies.